Literature DB >> 28280631

Gastric metastasis of bilateral breast cancer.

Omar Jmour1, Asma Belaïd1, Fahmi Mghirbi2, Khalil Béhi2, Raoudha Doghri3, Farouk Benna1.   

Abstract

Breast cancer is the most common malignancy in women. The most frequent metastatic sites are lung, bone, liver and brain. On the other hand, gastric metastases are rare. Synchronous bilateral breast cancer (SBBC) occurs rarely. Lobular carcinoma is the histological type most often associated with bilateral breast carcinomas and gastric metastases. We made a retrospective study including four patients followed in the Salah Azaiez Institute, for a bilateral breast cancer with gastric metastases. We analyzed the epidemiological, anatomoclinical and therapeutic particularities of this rare entity. Symptoms were unspecific. The diagnosis of gastric metastasis of the SBBC was confirmed by a histopathological examination of an endoscopic biopsy. The median age was 46.2 years (range, 36-51 years) and the median time until the gastric involvement was 19 months (range, 0-41 months). None of patients had a surgical treatment for the gastric location. All Patients received at least one line of chemotherapy and radiotherapy. Median survival following the detection of gastric involvement was 22 months (range, 1-56 months). Gastric metastases from breast cancer are rare and frequently associated with other distant metastasis. Symptoms are unspecific and endoscopy may not be contributive. Therefore, gastric involvement is underestimated. Lobular infiltrating carcinoma (LIC) is the most histological type incriminated in its occurrence. The supply of immunohistochemistry is crucial to distinguish between primary or metastatic gastric cancer.

Entities:  

Keywords:  Breast cancer; gastric metastasis; therapy

Year:  2017        PMID: 28280631      PMCID: PMC5334049          DOI: 10.21037/jgo.2016.10.03

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  18 in total

1.  Gastric metastasis of breast cancer: a single centre retrospective study.

Authors:  Maher M Almubarak; Marick Laé; Wulfran Cacheux; Patricia de Cremoux; Jean-Yves Pierga; Fabien Reyal; Simon P Bennett; Marie-Christine Falcou; Remy J Salmon; Bernard Baranger; Pascale Mariani
Journal:  Dig Liver Dis       Date:  2011-05-26       Impact factor: 4.088

Review 2.  Epidemiology of contralateral breast cancer.

Authors:  Y Chen; W Thompson; R Semenciw; Y Mao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-10       Impact factor: 4.254

3.  Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis.

Authors:  Elisabeth C McLemore; Barbara A Pockaj; Carol Reynolds; Richard J Gray; Jose L Hernandez; Clive S Grant; John H Donohue
Journal:  Ann Surg Oncol       Date:  2005-09-21       Impact factor: 5.344

4.  Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract.

Authors:  Fionnuala P O'Connell; Helen H Wang; Robert D Odze
Journal:  Arch Pathol Lab Med       Date:  2005-03       Impact factor: 5.534

5.  Metastatic breast cancer masquerading as gastrointestinal primary.

Authors:  R E Schwarz; D S Klimstra; A D Turnbull
Journal:  Am J Gastroenterol       Date:  1998-01       Impact factor: 10.864

6.  Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept.

Authors:  B G Taal; H Boot; P van Heerde; D de Jong; A A Hart; J M Burgers
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

7.  Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.

Authors:  Mattia Intra; Nicole Rotmensz; Giuseppe Viale; Luigi Mariani; Bernardo Bonanni; Mauro G Mastropasqua; Viviana Galimberti; Roberto Gennari; Paolo Veronesi; Marco Colleoni; Eleni Tousimis; Arianna Galli; Aron Goldhirsch; Umberto Veronesi
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

8.  The descriptive epidemiology of second primary breast cancer.

Authors:  Jonine L Bernstein; Robert H Lapinski; Seema S Thakore; John T Doucette; W Douglas Thompson
Journal:  Epidemiology       Date:  2003-09       Impact factor: 4.822

9.  Linitis plastica caused by metastatic lobular carcinoma of the breast.

Authors:  W J Cormier; T A Gaffey; J M Welch; J S Welch; J H Edmonson
Journal:  Mayo Clin Proc       Date:  1980-12       Impact factor: 7.616

Review 10.  Esophagogastric cancers secondary to a breast primary tumor do not require resection.

Authors:  A A Ayantunde; A Agrawal; S L Parsons; N T Welch
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.282

View more
  5 in total

1.  Breast cancer with an initial gastrointestinal presentation: a case report and literature review.

Authors:  Ling-Ling Zhang; Xiao-Cui Rong; Li Yuan; Li-Jing Cai; Yue-Ping Liu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 2.  Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes.

Authors:  Feifei Liu; Feng Zhang; Xiangyu Li; Qi Liu; Wei Liu; Peng Song; Ziying Qiu; Yu Dong; Hao Xiang
Journal:  Oncotarget       Date:  2017-07-08

3.  The Volatilomic Footprints of Human HGC-27 and CLS-145 Gastric Cancer Cell Lines.

Authors:  Andreas Leiherer; Daria Ślefarska; Marcis Leja; Christine Heinzle; Axel Mündlein; Ilze Kikuste; Linda Mezmale; Heinz Drexel; Chris A Mayhew; Paweł Mochalski
Journal:  Front Mol Biosci       Date:  2021-01-11

Review 4.  Widespread Metastasis to the Stomach 10 Years After Primary Breast Cancer: A case report and review of the literature.

Authors:  Ji-Xin Fu; Ya-Nan Zou; Xin-Jian Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

Review 5.  Rare sites of breast cancer metastasis: a review.

Authors:  Rosa Di Micco; Letizia Santurro; Maria Luisa Gasparri; Veronica Zuber; Enrico Fiacco; Guglielmo Gazzetta; Chanel Elisha Smart; Alice Valentini; Oreste Davide Gentilini
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.